Alivus Life Sciences Limited     (formerly Glenmark Life Sciences Limited) 
Corporate Office: Registered Office: 
Technopolis Knowledge Park, A wing, Office No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate  
4th Floor, Mahakali Caves Road, Andheri ( E), Mumbai – 400093  Mohol Bazarpeth, Solapur 413 213, India 
T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@ alivus.com   | W: www.alivus.com 
November 14, 2025 
T
o,  To, 
Dy. General Manager The Manager – Listing, 
Department of Corporate Services, National Stock Exchange of India Ltd., 
BSE Ltd.,  Plot No. C/1, G Block, 
P. J. Towers, Dalal Street,   Bandra Kurla Complex, 
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 
R
ef: Scrip Code: 543322 Ref: Scrip Name: ALIVUS 
D
ear Sirs, 
S
ub: Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) 
Regulations, 2015 – Intimation of Investors/Analyst Meeting 
With reference to the captioned subject and pursuant to Regulation 30 and Para A of Part A of 
Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find 
below details of the meetings with Investor/Analyst which will be attended by the representatives 
of the Company: 
Date Name Mode Place Type of Meeting 
November 19, 2025 Quantum AMC In-Person  Mumbai One on One 
November 24, 2025 Axis Securities PMS Virtual - One on One 
The schedule and mode of meeting may undergo a change due to exigencies on part of the 
Investor/Analyst/Company.  
You are requested to kindly take a note of the same. 
Thanking You, 
Your Sincerely, 
For Alivus Life Sciences Limited 
(formerly Glenmark Life Sciences Limited) 
R
udalf Corriea 
Company Secretary & Compliance Officer 
